Blood Screening Market Share

North American Market Forecast

The blood screening market in North America is projected to be the largest with a share of about 38% by the end of 2037. The higher demand for blood transfusion is forecasted to elevate the market growth in North America during the assessment period. Every year, around 21 million blood components are transfused in the United States. Further, the presence of a strong healthcare network in the region, along with the availability of supportive policies by regulatory bodies, is anticipated to contribute positively to the market's growth.

APAC Market Statistics

The Asia Pacific market is estimated to be the second largest, registering a share of about 25% by the end of 2037. The major factor that is attributed to creating a positive outlook for the market growth is the increasing spending capacity of opting for advanced medical facilities such as blood transfusion diagnostics along with the presence of a high number of medical facilities are also anticipated to hike the market growth further during the projected time frame in the region.